Drugs: Safety
The question
What discussions he has had with the Medicines and Healthcare products Regulatory Agency on how to accelerate the acceptance of data generated in non-animal methods for drug safety decision making.
Answered by Feryal Clark
The Medicines and Healthcare products Regulatory Agency (MHRA) attended a ministerial roundtable on accelerating the adoption of alternatives to using animals for drug development earlier this year.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →